药物涂层球囊治疗冠状动脉疾病的定义与标准化终点:DCB学术研究联盟共识文件
该共识由欧洲、美国及亚洲的学术研究组织与经皮冠状动脉介入学会合作制定,针对药物涂层球囊(DCB)治疗阻塞性冠状动脉疾病研究中缺乏标准化和可比性的问题,旨在统一临床试验的设计与终点,包括病变评估的血管造影、血管内及无创影像方法,并讨论血运重建后药物治疗及「混合治疗」概念。
要点
- 统一DCB临床试验的设计、终点定义与随访方案,提高研究间可比性。
- 明确病变评估的血管造影、血管内影像及无创影像方法。
- 提出「混合治疗」理念,倡导联合器械策略。
核心结论
- 该共识为药物涂层球囊治疗冠状动脉疾病的临床试验提供标准化设计与终点定义,以促进研究间一致性和可比性。
研究设计与样本
- 由欧洲、美国及亚洲的学术研究组织与经皮冠状动脉介入学会协作制定的共识文件。
关键数值与推荐
- 统一临床试验的设计、终点定义、随访方案及分析方法。
- 定义病变评估的血管造影、血管内及无创影像方法。
- 讨论血运重建后药物治疗的考虑及「混合治疗」概念。
临床怎么用
- 为介入心脏病学家和试验研究者提供DCB临床研究设计与终点选择的标准化指导。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Drug Coated Balloon Academic Research Consortium project originated from the lack of standardization and comparability between studies using drug-coated balloons in the treatment of obstructive coronary artery disease. This document is a collaborative effort between academic research organizations and percutaneous coronary intervention societies in Europe, the USA, and Asia. This consensus sought to standardize study designs and endpoints for clinical trials involving drug-coated balloons, including defining angiographic, intravascular, and non-invasive imaging methods for lesion assessment, alongside considerations for post-revascularization pharmaco-therapy. The concept of 'blended therapy', which advocates for combining device strategies, is also discussed. This paper delineates study types, endpoint definitions, follow-up protocols, and analytical approaches, aiming to provide consistency and guidance for interventional cardiologists and trialists.
引用
- Fezzi, Scheller, Cortese, et al. Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium. Eur Heart J. 2025. PMID: 40270117. doi:10.1093/eurheartj/ehaf029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。